Pierre-Jean Saulnier1,2, Manjula Darshi3, Kevin M Wheelock1, Helen C Looker1, Gudeta D Fufaa1, William C Knowler1, E Jennifer Weil1, Stephanie K Tanamas1, Kevin V Lemley4, Rintaro Saito3, Loki Natarajan3, Robert G Nelson5,6, Kumar Sharma3. 1. Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, USA. 2. Clinical Investigation Center CIC1402, CHU Poitiers, University of Poitiers, INSERM, Poitiers, France. 3. University of California San Diego, San Diego, CA, USA. 4. University of Southern California, Los Angeles, CA, USA. 5. Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, USA. rnelson@nih.gov. 6. National Institutes of Health, 1550 East Indian School Road, Phoenix, AZ, 85014-4972, USA. rnelson@nih.gov.
Abstract
INTRODUCTION: Little is known about the association of urine metabolites with structural lesions in persons with diabetes. OBJECTIVES: We examined the relationship between 12 urine metabolites and kidney structure in American Indians with type 2 diabetes. METHODS: Data were from a 6-year clinical trial that assessed renoprotective efficacy of losartan, and included a kidney biopsy at the end of the treatment period. Metabolites were measured in urine samples collected within a median of 6.5 months before the research biopsy. Associations of the creatinine-adjusted urine metabolites with kidney structural variables were examined by Pearson's correlations and multivariable linear regression after adjustment for age, sex, diabetes duration, hemoglobin A1c, mean arterial pressure, glomerular filtration rate (iothalamate), and losartan treatment. RESULTS: Participants (n = 62, mean age 45 ± 10 years) had mean ± standard deviation glomerular filtration rate of 137 ± 50 ml/min and median (interquartile range) urine albumin:creatinine ratio of 34 (14-85) mg/g near the time of the biopsy. Urine aconitic and glycolic acids correlated positively with glomerular filtration surface density (partial r = 0.29, P = 0.030 and r = 0.50, P < 0.001) and total filtration surface per glomerulus (partial r = 0.32, P = 0.019 and r = 0.43, P = 0.001). 2-ethyl 3-OH propionate correlated positively with the percentage of fenestrated endothelium (partial r = 0.32, P = 0.019). Citric acid correlated negatively with mesangial fractional volume (partial r=-0.36, P = 0.007), and homovanillic acid correlated negatively with podocyte foot process width (partial r=-0.31, P = 0.022). CONCLUSIONS: Alterations of urine metabolites may associate with early glomerular lesions in diabetic kidney disease.
INTRODUCTION: Little is known about the association of urine metabolites with structural lesions in persons with diabetes. OBJECTIVES: We examined the relationship between 12 urine metabolites and kidney structure in American Indians with type 2 diabetes. METHODS: Data were from a 6-year clinical trial that assessed renoprotective efficacy of losartan, and included a kidney biopsy at the end of the treatment period. Metabolites were measured in urine samples collected within a median of 6.5 months before the research biopsy. Associations of the creatinine-adjusted urine metabolites with kidney structural variables were examined by Pearson's correlations and multivariable linear regression after adjustment for age, sex, diabetes duration, hemoglobin A1c, mean arterial pressure, glomerular filtration rate (iothalamate), and losartan treatment. RESULTS:Participants (n = 62, mean age 45 ± 10 years) had mean ± standard deviation glomerular filtration rate of 137 ± 50 ml/min and median (interquartile range) urine albumin:creatinine ratio of 34 (14-85) mg/g near the time of the biopsy. Urine aconitic and glycolic acids correlated positively with glomerular filtration surface density (partial r = 0.29, P = 0.030 and r = 0.50, P < 0.001) and total filtration surface per glomerulus (partial r = 0.32, P = 0.019 and r = 0.43, P = 0.001). 2-ethyl 3-OH propionate correlated positively with the percentage of fenestrated endothelium (partial r = 0.32, P = 0.019). Citric acid correlated negatively with mesangial fractional volume (partial r=-0.36, P = 0.007), and homovanillic acid correlated negatively with podocyte foot process width (partial r=-0.31, P = 0.022). CONCLUSIONS: Alterations of urine metabolites may associate with early glomerular lesions in diabetic kidney disease.
Entities:
Keywords:
Biomarkers; Kidney structure; Metabolites; Type 2 Diabetes
Authors: Jennifer L Pluznick; Ryan J Protzko; Haykanush Gevorgyan; Zita Peterlin; Arnold Sipos; Jinah Han; Isabelle Brunet; La-Xiang Wan; Federico Rey; Tong Wang; Stuart J Firestein; Masashi Yanagisawa; Jeffrey I Gordon; Anne Eichmann; Janos Peti-Peterdi; Michael J Caplan Journal: Proc Natl Acad Sci U S A Date: 2013-02-11 Impact factor: 11.205
Authors: Gudeta D Fufaa; E Jennifer Weil; Kevin V Lemley; William C Knowler; Frank C Brosius; Berne Yee; Michael Mauer; Robert G Nelson Journal: Clin J Am Soc Nephrol Date: 2016-01-20 Impact factor: 8.237
Authors: Jakk Wong; Yvette M Piceno; Todd Z DeSantis; Madeleine Pahl; Gary L Andersen; Nosratola D Vaziri Journal: Am J Nephrol Date: 2014-03-08 Impact factor: 3.754
Authors: Pierre-Jean Saulnier; Kevin M Wheelock; Scott Howell; E Jennifer Weil; Stephanie K Tanamas; William C Knowler; Kevin V Lemley; Michael Mauer; Berne Yee; Robert G Nelson; Paul J Beisswenger Journal: Diabetes Date: 2016-09-08 Impact factor: 9.461
Authors: Timothy Vigers; Carissa Vinovskis; Lu-Ping Li; Pottumarthi Prasad; Hiddo Heerspink; Angelo D'Alessandro; Julie A Reisz; Federica Piani; David Z Cherney; Daniel H van Raalte; Kristen J Nadeau; Meda E Pavkov; Robert G Nelson; Laura Pyle; Petter Bjornstad Journal: Pediatr Nephrol Date: 2022-05-04 Impact factor: 3.714
Authors: Salina Moon; John J Tsay; Heather Lampert; Zaipul I Md Dom; Aleksandar D Kostic; Adam Smiles; Monika A Niewczas Journal: Sci Rep Date: 2021-04-21 Impact factor: 4.996
Authors: William P Martin; Yeong H D Chuah; Mahmoud Abdelaal; Anders Pedersen; Daniel Malmodin; Sanna Abrahamsson; Michaela Hutter; Catherine Godson; Eoin P Brennan; Lars Fändriks; Carel W le Roux; Neil G Docherty Journal: Front Endocrinol (Lausanne) Date: 2022-01-26 Impact factor: 5.555